Table 1.
Current protocols of neuronal differentiation using NGN2 overexpression
| Neuronal subtype | Source/species | Transcription factors used and method of delivery | NGN2 induction duration | Time to functional neurons | Developmental patterning | Growth factors and co-culture | Reference |
|---|---|---|---|---|---|---|---|
| Bipolar neurons | Human ESCs and iPSCs | Ngn2 and Ngn1 via lentiviral gene delivery | 1–4 days | 4 days for single action potentials, 14 days for action potentials trains | NA | Co-cultured with rat astrocytes | (Busskamp et al., 2014) |
| Glutamatergic excitatory neurons | Human ESC and iPSCs | Ngn2 via lentiviral gene delivery | Entire duration | 2 weeks | NA | BDNF | (Zhang et al., 2013) |
| Mouse ESCs | Transient Ngn2 expression and clonal transgenic line | Entire duration | 7 days | NA | NA | (Thoma et al., 2012) | |
| NPCs derived from human iPSCs | Ngn2 or NGN2 via lentiviral gene delivery | 2 days–3 weeks | 2 weeks | SB431542 and LDN193189 | NA | (Ho et al., 2016) | |
| Human iPSCs | NGN2 transgenic line (i3 neurons) | 72 h | 2 weeks | NA | BDNF, NT-3 co-cultured with primary mouse astrocytes (also recommend using astrocyte conditioned media) | (Fernandopulle et al., 2018) | |
| Human ESCs and iPSCs | Ngn2 via lentiviral gene delivery | Entire duration | 2–3 weeks | SB431542, XAV939, and LDN193189 | Co-cultured with mouse primary cortical glial cells | (Nehme et al., 2018) | |
| Human ESCs or ESC-derived anterior and posterior NPCs | NGN2 alone or in addition to one of the following: EMX1, EMX2, OTX1, OTX2, EOMES (TBR2), LHX2, or FOXG1 | 4 days or for single-cell RNA sequencing 14 days | 28 days | SB431542, LDN193189 and CHIR99021 | Co-cultured with mouse glia for long term cultures | (Ang et al., 2020) | |
| Dopaminergic neuron-like | Human fibroblasts | NGN2, ASCL1, SOX2, NURR1, PITX3 via lentiviral gene delivery | Transient | 20 days | SHH, FGF8 | NA | (Liu et al., 2012) |
| Midbrain dopaminergic neurons | Human iPSCs | NGN2, ATOH1 via synthetic mRNA delivery | Multiple mRNA transfections: ATOH1 for 3 days, NGN2 for 1 day | 20–49 days | SHH, FGF8b, and DAPT | BDNF, GDNF, TGFb-3, cAMP, ascorbic acid, and DAPT | (Xue et al., 2019) |
| Dopaminergic neuron | Mouse ESC-derived NPCs | Ngn2, Nurr1 via retroviral gene delivery | 3–10 days | 9–16 + days | bFGF, EGF | NA | (Park et al., 2008) |
| Serotonergic neurons | Human dermal fibroblasts | NGN2, ASCL1, NKX2.2, FEV, GATA2, LMX1B via lentiviral gene delivery | 3–4 weeks | 6 weeks | Dibutyryl cyclic-AMP, noggin, LDN193189, A83-1, CHIR99021, SB431542, forskolin | GDNF, BDNF, dibutyryl cyclic-AMP co-culture with primary rodent astrocytes for electrophysiological analyses | (Vadodaria et al., 2016) |
| Motor neurons | Human ESC and iPSCs | NGN2 NGN1, NGN3, ND1, ND2 via synthetic mRNA delivery | 2–4 transient transfections | 7–10 days | Forskolin, SB431542, dorsomorphin, retinoic acid | BDNF, GDNF, NT-3 | (Goparaju et al., 2017) |
| Human ESC and iPSC-derived NPCs | NGN2, ISL1, LHX3 via adenoviral gene delivery | Transduce day 0 and 4 | 21 days | Retinoic acid, forskolin, SHH | Retinoic acid, SHH | (Hester et al., 2011) | |
| Spinal motor neurons | Mouse ESC-derived EBs | Ngn2, Isl1, Lhx3 via inducible transgenic line | 2 days | 7–11 day | NA | Co-culture with mouse astrocytes 7–10 days | (Mazzoni et al., 2013) |
| Mouse and human fibroblasts | Ngn2, Ascl1, Brn2, Mytl1, Lhx3, Hb9, Isl1 via retroviral transduction | Undefined | 21 + days | NA | GDNF, BDNF, CNTF | (Son et al., 2011) | |
| Human iPSCs | Ngn2, Isl1, Lhx3 inducible line via a piggyBac transposon vector | 5 days | 13 days | DAPT, SU5402 | BDNF, GDNF, L-ascorbic acid | (Garone et al., 2019) | |
| Cranial motor neurons | Mouse ESCs-derived EBs | Ngn2, Isl1, Phox2a via inducible transgenic line | 2 days | 11 days | NA | Co-culture with mouse astrocytes 7–10 days | (Mazzoni et al., 2013) |
| Human iPSCs | Ngn2, Isl1, Phox2a inducible line via a piggyBac transposon vector | 5 days | 13 days | DAPT, SU5402 | BDNF, GDNF, L-ascorbic acid | (Garone et al., 2019) | |
| Lower motor neurons | Human iPSCs | NGN2, ISL1, LHX3 inducible transgenic line | 72 h | 14 + days | NA | Optional co-culture of astrocytes | (Fernandopulle et al., 2018) |
| Cholinergic motor neurons | Human fetal lung fibroblasts or human postnatal and adult skin fibroblasts | NGN2 (+Sox11 for skin fibroblasts) using retroviral gene delivery | 2–35 days | 50 days | Dorsomorphin and forskolin | Co-cultured with C2C12 murine myoblast line | (Liu et al., 2013) |
| Mixed population of sensory neurons | Human and mouse fibroblasts | Ngn2 and BRN3A or Ngn1 and BRN3A via lentiviral transduction | 8 days | 14–22 days | NA | BDNF, GDNF, NGF | (Blanchard et al., 2015) |
| Mixed population of sensory neurons | Human ESC neural crest progenitors | NGN2 via lentiviral transduction | 4 days | 32 days | SB431524, CHIR99021, BMP2, FGF2 | BDNF, GDNF, NT-3, bNGF, Y-27632 | (Hulme et al., 2020) |
| Cold-sensing mechanoreceptors | Human iPSCs or iPSC-derived neural crest cells | NGN2 and BRN3A via an inducible line | 14 days | 20 days | Y-27632, bFGF, EGF, SB431524 | BDNF, GDNF, NT-3, bNGF, Y-27632 | (Nickolls et al., 2020) |
| Mechanoreceptors | Human iPSC-derived neural crest cells | NGN2 and BRN3A via an inducible line | 1 day | 20 days | Y-27632, bFGF, EGF, SB431524 | BDNF, GDNF, NT-3, bNGF Retinoic acid | (Nickolls et al., 2020) |
| Human ESC and iPSC neural crest progenitors | NGN2 via lentiviral transduction | 1 day | 21– 30 days | FGF, EGF | BDNF, GDNF, NT-3, bNGF Retinoic acid | (Schrenk-Siemens et al., 2015) |